Tyrosine kinome
    7.
    发明授权
    Tyrosine kinome 有权
    酪氨酸激酶

    公开(公告)号:US09206467B2

    公开(公告)日:2015-12-08

    申请号:US13746376

    申请日:2013-01-22

    Abstract: Protein kinases are important signaling molecules involved in tumorigenesis. Mutational analysis of the human tyrosine kinase gene family (98 genes) identified somatic alterations in −20% of colorectal cancers, with the majority of mutations occurring in NTRK3, FES, GUCY2F and a previously uncharacterized tyrosine kinase gene called MCCK/MLK4. Most alterations were in conserved residues affecting key regions of the kinase domain. These data represent a paradigm for the unbiased analysis of signal transducing genes in cancer and provide useful targets for therapeutic intervention.

    Abstract translation: 蛋白激酶是参与肿瘤发生的重要信号分子。 人类酪氨酸激酶基因家族(98个基因)的突变分析鉴定了-20%的结肠直肠癌的体细胞变化,大部分突变发生在NTRK3,FES,GUCY2F和以前称为MCCK / MLK4的未表征的酪氨酸激酶基因。 大多数改变是保守的残基影响激酶结构域的关键区域。 这些数据代表了癌症中信号转导基因的无偏见分析的范例,并为治疗干预提供了有用的目标。

Patent Agency Ranking